| abstract |
The present invention provides chimeric and humanized antibodies, human PD-1 antibodies, and antigen-binding fragments thereof, which comprise a human PD-I antibody, an antigen-binding fragment thereof, and pharmaceutical uses thereof and comprising a complementarity determining region (CDR) The present invention further provides the use of the antibody in the manufacture of a medicament for treating a disease or disorder. |